148 related articles for article (PubMed ID: 7586547)
1. Relation between cathepsin D expression and other prognostic factors in breast carcinomas.
Shaheen RM; Miseljic S; Wiehle RD; Wittliff JL
Clin Chem; 1995 Nov; 41(11):1585-91. PubMed ID: 7586547
[TBL] [Abstract][Full Text] [Related]
2. [Cytosolic concentrations of cathepsin D in 88 infiltrating ductal breast carcinomas having negative estrogen and progesterone receptors. Correlation with other clinical and biological parameters].
Ruibal A; Arias J; Lapeña G; García Díez S; Tejerina A
Rev Esp Med Nucl; 2001 Jun; 20(4):332-3. PubMed ID: 11940423
[No Abstract] [Full Text] [Related]
3. Enzyme-linked immunosorbent assay of HER-2/neu gene product (p185) in breast cancer: its correlation with sex steroid receptors, cathepsin D and histologic grades.
Marsigliante S; Muscella A; Ciardo V; Barker S; Leo G; Baker V; Mottaghi A; Vinson GP; Storelli C
Cancer Lett; 1993 Dec; 75(3):195-206. PubMed ID: 7906196
[TBL] [Abstract][Full Text] [Related]
4. Comparison of cathepsin D determinations in human carcinomas by enzyme immunoassay and immunoradiometric assay.
Shaheen RM; Miseljic S; Doering DL; Wittliff JL
J Clin Lab Anal; 1995; 9(6):351-8. PubMed ID: 8587002
[TBL] [Abstract][Full Text] [Related]
5. Quantitative analyses of epidermal growth factor receptors, HER-2/neu oncoprotein and cathepsin D in nonmalignant and malignant uteri.
Sanfilippo JS; Miseljic S; Yang AR; Doering DL; Shaheen RM; Wittliff JL
Cancer; 1996 Feb; 77(4):710-6. PubMed ID: 8616763
[TBL] [Abstract][Full Text] [Related]
6. Cathepsin D levels in primary breast cancers: relationship with epidermal growth factor receptor, oestrogen receptor and axillary nodal status.
Sacks NP; Smith K; Norman AP; Greenall M; LeJeune S; Harris AL
Eur J Cancer; 1993; 29A(3):426-8. PubMed ID: 8398346
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of cathepsin D and c-erbB-2 oncoprotein in a subgroup of node-negative breast cancer patients with low histological grade tumors.
Gaci Z; Bouin-Pineau MH; Gaci M; Daban A; Ingrand P; Métayé T
Int J Oncol; 2001 Apr; 18(4):793-800. PubMed ID: 11251176
[TBL] [Abstract][Full Text] [Related]
8. Cathepsin D assay in ovarian cancer: correlation with pathological features and receptors for oestrogen, progesterone and epidermal growth factor.
Scambia G; Benedetti P; Ferrandina G; Battaglia F; Baiocchi G; Mancuso S
Br J Cancer; 1991 Jul; 64(1):182-4. PubMed ID: 1854619
[TBL] [Abstract][Full Text] [Related]
9. Tumour epidermal growth factor receptor, erbB-2 and cathepsin D in node-negative invasive breast cancer: their impact on the selection of patients for systemic adjuvant therapy.
Tonkin KS; McKay JW; Stitt LW; Tokmakejian S; Haines DS
Cancer Prev Control; 1999 Apr; 3(2):131-6. PubMed ID: 10474760
[TBL] [Abstract][Full Text] [Related]
10. Specific oncological contribution of cathepsin D and pS2 in human breast cancer: their relationship with TNM status, estradiol receptors, epidermal growth factor receptor and neu amplification.
Bolufer P; Torregrosa MD; Gomez L; Munarriz B; López JA; Asins E; Espinoza S; Vera F; Vazquez C; Guillem V
Clin Chim Acta; 1996 Mar; 247(1-2):89-103. PubMed ID: 8920230
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of cathepsin D as prognostic predictor in breast cancer.
Barbi GP; Margallo E; Margiocco M; Paganuzzi M; Marroni P; Costanzi B; Gatteschi B; Tanara G; Spina B; Nicolò G
Oncology; 1994; 51(4):329-33. PubMed ID: 8208515
[TBL] [Abstract][Full Text] [Related]
12. Association between high concentrations of Mr 52,000 cathepsin D and poor prognosis in primary human breast cancer.
Thorpe SM; Rochefort H; Garcia M; Freiss G; Christensen IJ; Khalaf S; Paolucci F; Pau B; Rasmussen BB; Rose C
Cancer Res; 1989 Nov; 49(21):6008-14. PubMed ID: 2790815
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase expression in human breast cancer: an immunohistochemical study including correlation with cathepsin D, type IV collagen, laminin, fibronectin, EGFR, c-erbB-2 oncoprotein, p53, steroid receptors status and proliferative indices.
Ioachim EE; Athanassiadou SE; Kamina S; Carassavoglou K; Agnantis NJ
Anticancer Res; 1998; 18(3A):1665-70. PubMed ID: 9673387
[TBL] [Abstract][Full Text] [Related]
14. Measurement of erbB-2 oncoprotein in human breast cancers by ELISA.
Nugent A; McDermott E; O'Higgins N; Fennelly JJ; Duffy MJ
Biochem Soc Trans; 1992 Feb; 20(1):82S. PubMed ID: 1353039
[No Abstract] [Full Text] [Related]
15. Tumor histology and stage but not p53, Her2-neu or cathepsin-D expression are independent prognostic factors in breast cancer patients.
Korkolis DP; Tsoli E; Fouskakis D; Yiotis J; Koullias GJ; Giannopoulos D; Papalambros E; Nikiteas NI; Spiliopoulou CA; Patsouris E; Asimacopoulos P; Gorgoulis VG
Anticancer Res; 2004; 24(3b):2061-8. PubMed ID: 15274401
[TBL] [Abstract][Full Text] [Related]
16. [Value of immunohistochemical determination of receptors, tissue proteases, tumor suppressor proteins and proliferation markers as prognostic indicators in primary breast carcinoma].
Göhring UJ; Scharl A; Ahr A
Geburtshilfe Frauenheilkd; 1996 Apr; 56(4):177-83. PubMed ID: 8682282
[TBL] [Abstract][Full Text] [Related]
17. [Expression of cathepsin D in breast cancer and its clinical and histopathological correlations].
Ramírez-Ortega MC; Frías-Mendívil M; Delgado-Chávez R; Meneses-García A; Carrillo-Hernández JF; Ramírez-Ugalde MT; Zeichner-Gancz I
Rev Invest Clin; 1997; 49(5):361-8. PubMed ID: 9527695
[TBL] [Abstract][Full Text] [Related]
18. Associations between insulin-like growth factors and their binding proteins and other prognostic indicators in breast cancer.
Yu H; Levesque MA; Khosravi MJ; Papanastasiou-Diamandi A; Clark GM; Diamandis EP
Br J Cancer; 1996 Oct; 74(8):1242-7. PubMed ID: 8883411
[TBL] [Abstract][Full Text] [Related]
19. Immunoradiometric detection of pS2 and total cathepsin D in primary breast cancer biopsies: their correlation with steroid receptors.
Marsigliante S; Biscozzo L; Correale M; Paradiso A; Leo G; Abbate I; Dragone CD; Storelli C
Br J Cancer; 1994 Mar; 69(3):550-4. PubMed ID: 8123486
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of cathepsin D concentration in tumor cytosol of primary breast cancer.
Rodríguez J; Vázquez J; Corte MD; Lamelas M; Bongera M; Corte MG; Alvarez A; Allende M; Gonzalez L; Sánchez M; Vijande M; Garcia Muñiz J; Vizoso F
Int J Biol Markers; 2005; 20(2):103-11. PubMed ID: 16011040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
